(Q34030691)

30 July 2017

title

Chronic migraine--classification, characteristics and treatment (English)

1 reference

30 July 2017

1 reference

5

Jes Olesen

0 references

Richard B. Lipton

series ordinal

4

object named as

Richard B Lipton

1 reference

30 July 2017

3

Peter J Goadsby

1 reference

30 July 2017

Hans-Christoph Diener

series ordinal

1

object named as

Hans-Christoph Diener

1 reference

30 July 2017

Stephen D. Silberstein

series ordinal

6

object named as

Stephen D Silberstein

1 reference

30 July 2017

2

David W Dodick

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

30 July 2017

published in

Nature Reviews Neurology

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

162-171

1 reference

CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Clinical practice. Chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Chronic frequent headache in the general population: comorbidity and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Quality of life in migraine and chronic daily headache patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Quality-of-life differences between patients with episodic and transformed migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Quality of life in chronic daily headache: a study in a general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Migraine headache disability and health-related quality-of-life: a population-based case-control study from England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Epidemiology of headache in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

The global burden of headache: a documentation of headache prevalence and disability worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

New appendix criteria open for a broader concept of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Chronic migraine classification: current knowledge and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

21 January 2018

Special Communication

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Classification of daily and near-daily headaches: proposed revisions to the IHS criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

The International Classification of Headache Disorders: 2nd edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Global prevalence of chronic migraine: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Factors associated with the onset and remission of chronic daily headache in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Concepts and mechanisms of migraine chronification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Excessive opioid use and the development of chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Overuse of acute migraine medications and migraine chronification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Deconstructing migraine headache into peripheral and central sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Refractory migraine and chronic migraine: pathophysiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Stimulation of cranial vessels excites nociceptive neurones in several thalamic nuclei of the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Brain stem activation in spontaneous human migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

A positron emission tomographic study in spontaneous migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Brainstem activation specific to migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Interictal dysfunction of a brainstem descending modulatory center in migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Is chronic migraine one end of a spectrum of migraine or a separate entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Spectrum of illness: understanding biological patterns and relationships in chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Features of medication overuse headache following overuse of different acute headache drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Probable medication-overuse headache: the effect of a 2-month drug-free period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

21 January 2018

Integrated headache care

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

A review of current European treatment guidelines for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Behavioral treatment strategies for migraine and tension-type headache: a review of the evidence and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

The effect of sodium valproate on chronic daily headache and its subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Topiramate in the Treatment of Chronic Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin A and chronic low back pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Animal models of migraine: looking at the component parts of a complex disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

A randomized, controlled trial of acupuncture for chronic daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Carthami-Semen acupuncture point injection for chronic daily headache: a pilot, randomised, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Behavioral sleep modification may revert transformed migraine to episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Disability Pattern in Chronic Migraine With Medication Overuse: A Comparison With Migraine Without Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Transformation of episodic migraine into daily headache: analysis of factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

"Chronic daily headache" ("cefalea cronica quotidiana")

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

The mixed headache syndrome: a new perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

31 March 2020

Transformed migraine.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Classification of daily and near-daily headaches: field trial of revised IHS criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Rates, predictors, and consequences of remission from chronic migraine to episodic migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

31 March 2020

Neurobiology of migraine

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Studies of the brain structures involved in diffuse noxious inhibitory controls: the mesencephalon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Diagnostic and therapeutic guidelines for migraine. Italian Society for the Study of Headaches (SISC)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.13

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

31 March 2020

1 reference

12 December 2020

Triptan-induced latent sensitization: a possible basis for medication overuse headache

1 reference

12 December 2020

Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.

1 reference

12 December 2020

Quality of life and disability in primary chronic daily headaches.

1 reference

12 December 2020

Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2012.13

1 reference

Dimensions Publication ID

30 July 2017

1042236868

0 references

1 reference